ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1069

Renal Involvement Other Than Renal Crisis in Systemic Sclerosis: A Retrospective Monocentric Cohort Study

Gaelle Becel1, Bertrand Dunogue1, Benjamin Chaigne1, Benjamin Thoreau2, Alexis Regent1, Alexandre Karras3, Benjamin Terrier1 and Luc Mouthon1, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2AP-HP, Université Paris Cité, INSERM U1016, CNR UMR 8104, Paris, France, 3HEGP, Paris, France

Meeting: ACR Convergence 2022

Keywords: Renal, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Scleroderma renal crisis has extensively been described over the past decades because of its severity. The use of angiotensin-converting enzyme inhibitors has clearly improved its outcome. However, few data are available on chronic renal impairment in systemic sclerosis (SSc). The aim of this study is to describe the different types of renal involvement observed in SSc in order to establish their frequency and to identify potential predictive factors.

Methods: Clinical and biological data from patients with systemic sclerosis (SSc) cared for in our Internal Medicine Department between 01/01/1989 and 12/31/2020 were retrospectively analyzed. Diagnosis was based on the 2013 ACR/EULAR Classification Criteria for SSc. At least two measurements of serum creatinine during follow up assessments were required for inclusion in this study. Patients who presented a renal crisis, chronic renal failure (glomerular filtration rate CKD-EPI < 60 mL/min/1.73 m2) or proteinuria (at least one sample proteinuria value > 0.5 g/g among the available values) during their follow-up were identified.

Results: 649 patients including 106 males (16%) were included in this study; 6% of them developed a renal crisis, 13% a chronic renal failure and 11% a proteinuria. Chronic renal failure and proteinuria occurred without renal crisis in about 70% of cases.

Chronic renal failure was significantly associated with age, high blood pressure (OR 4.5, 95% CI [3.0 ; 6.6], p < 0.05), pulmonary hypertension (OR 4.0, 95% CI [2.7 ; 6.1], p < 0.05) and digital ulcers (OR 1.8, 95% CI [1.1 ; 2.8], p < 0.05) (Table 1). Among patients with no history of renal crisis, chronic renal failure occurred more often in those with anti-centromere antibodies (OR 2.3, 95% CI [1.4 ; 3.8], p < 0.05). Proteinuria was significantly more frequent in patients with interstitial lung disease (OR 1.9, 95% CI [1.2 ; 3.1], p< 0.05) and diffuse SSc (OR 2.5, 95% CI [1.6 ; 3.9], p< 0.05), and in the presence of anti-DNA, ANCA anti-MPO or anti-PR3, anti-RNP and anti-fibrillarin antibodies (Table 2). The onset of proteinuria was also linked to the severity of skin involvement.

Conclusion: Chronic renal failure and proteinuria occur mostly in the absence of a scleroderma renal crisis. Better knowledge and understanding of the underlying mechanisms of renal disease in SSc should allow for improved screening and treatment.

Supporting image 1

Supporting image 2


Disclosures: G. Becel, None; B. Dunogue, None; B. Chaigne, None; B. Thoreau, None; A. Regent, None; A. Karras, Roche, Gilead, Amgen; B. Terrier, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb(BMS), Eli Lilly, LFB, Boehinger Ingelheim, Vifor Pharma, Pfizer, Roche; L. Mouthon, Boehringer-Ingelheim, LFB.

To cite this abstract in AMA style:

Becel G, Dunogue B, Chaigne B, Thoreau B, Regent A, Karras A, Terrier B, Mouthon L. Renal Involvement Other Than Renal Crisis in Systemic Sclerosis: A Retrospective Monocentric Cohort Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/renal-involvement-other-than-renal-crisis-in-systemic-sclerosis-a-retrospective-monocentric-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/renal-involvement-other-than-renal-crisis-in-systemic-sclerosis-a-retrospective-monocentric-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology